Intra-Cellular Therapies, Inc.
2019 Q4 - 2025 Q1 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q1 | 5/14/2025 | 8,336 | 0.0% | 63,192 | 3/31/2025 |
| 2024 Q4 | 2/19/2025 | 6,939 | 0.0% | 83,080 | 12/31/2024 |
| 2024 Q3 | 11/15/2024 | 6,624 | 0.0% | 90,529 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 6,328 | 0.0% | 92,390 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 3,863 | 0.0% | 55,830 | 3/31/2024 |
| 2023 Q4 | 2/16/2024 | 4,021 | 0.0% | 56,138 | 12/31/2023 |
| 2023 Q3 | 12/19/2023 | 2,924 | 0.0% | 56,138 | 9/30/2023 |
| 2023 Q2 | 12/19/2023 | 2,870 | 0.0% | 45,319 | 6/30/2023 |
| 2023 Q1 | 12/19/2023 | 3,263 | 0.0% | 60,262 | 3/31/2023 |
| 2022 Q4 | 12/19/2023 | 3,189 | 0.0% | 60,262 | 12/31/2022 |
| 2022 Q3 | 11/15/2022 | 3,188 | 0.0% | 68,509 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 4,652 | 0.0% | 81,502 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 6,361 | 0.0% | 103,958 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 4,981 | 0.0% | 95,158 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 3,547 | 0.0% | 95,158 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 3,884 | 0.0% | 95,158 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 3,229 | 0.0% | 95,158 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 3,026 | 0.0% | 95,158 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 2,086 | 0.0% | 81,275 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 1,645 | 0.0% | 64,096 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 985 | 0.0% | 64,096 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 1,724 | 0.0% | 50,243 | 12/31/2019 |